Hepatitis C virus entry: potential receptors and their biological functions.
about
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domainHepatitis C virus proteinsThe tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusMonoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusRole of the Low-Density Lipoprotein Receptor in Entry of Bovine Viral Diarrhea VirusThe Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host CellsTransmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus EntrySuperinfection Exclusion in Cells Infected with Hepatitis C VirusHuman Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into CellsThe Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope ProteinHigh-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density LipoproteinCharacterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C VirusExpression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 BindingEffect of Cell Polarization on Hepatitis C Virus EntryThe CD81 Partner EWI-2wint Inhibits Hepatitis C Virus EntryCD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus EntryCorrelation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C VirusHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinBinding of liver derived, low density hepatitis C virus to human hepatoma cellsCD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human HepatocytesApolipoprotein C1 Association with Hepatitis C VirusViruses as co-factors for the initiation or exacerbation of lung fibrosisCell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsAnalysis of a conserved RGE/RGD motif in HCV E2 in mediating entryResidues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell ContactsA computational approach identifies two regions of Hepatitis C Virus E1 protein as interacting domains involved in viral fusion processMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryCS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus InternalizationComparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver CellsHuman hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivoClaudin association with CD81 defines hepatitis C virus entry.Advancement in the development of models for hepatitis C research.Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web.Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs)The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infectionFunctional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome displayScreening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling
P2860
Q21090524-DF9E25F0-E46A-48F1-9C56-3CC5AFF6021EQ24563969-2B811424-3B84-4FC2-8600-5405858A3F4DQ24652906-C4D720AF-8A67-4A68-870D-765D760D0AC4Q26783378-5C8BD07A-F4F8-47C3-9826-E9AA20D081C9Q27477607-47B281E8-55EF-4874-9759-9250D65B7290Q27478044-22FC4D59-E8B3-4B01-BCA2-83ED49716C4BQ27478363-423268D0-92A5-4C89-91DB-7A4DB6B32238Q27478378-9F88F42C-15AA-4B6D-A78E-04BF1EF01EAAQ27480362-AB0EE63D-864F-4EA0-A65D-EC5437634081Q27481009-425AABBC-EBC4-4957-B001-6E8B67BA40B4Q27481010-24685AD9-95F4-4376-9E21-60EAA5F6E051Q27481024-95AF3818-FEB7-45DB-BD25-B23007753A09Q27481026-15A1C939-AEE2-4D26-8339-AA9C7FD19978Q27485293-E5F40607-E7D5-449D-B4AC-A3BA44F2F15CQ27485588-E7EE8AB0-ADCD-413E-984A-7A0352171867Q27485899-5C9556D4-7015-4217-A935-26426F92A173Q27486250-4EE651C4-3FBA-4300-88D2-60952BDA9505Q27486411-683B997F-13F6-45AE-96A8-B9951FE1E1D7Q27486525-40FFFC05-A696-4517-BD10-FDC7478FB680Q27486789-F67566CA-2915-442B-8EAF-E282AD475748Q27486923-F4626B67-50A1-4CAE-9518-304AE2875C2DQ27487313-C575C0FC-D130-4169-9305-0AD89B141B58Q27487385-33C543AB-CB97-40D6-B5B0-0CE97E4EE7E7Q27487872-DBC43557-A780-4878-9ABE-FE01457C236EQ27488396-76BF907F-F5A6-4595-AC7F-2171FCD50550Q27489412-7B8224D5-9B05-4B34-9C07-C6A601C27194Q27489898-8C54D4BD-B86C-463A-9E48-8B7DF54F87E9Q27490421-C65F8CCD-F1DE-408C-A80F-447CB1462093Q27490466-4B2ADE09-F6ED-442F-900B-8D470C3A9309Q28115022-9857E40D-F15C-40A5-8C43-7D590968619FQ28265835-0FCDFFC9-850A-4DB6-997E-682710DE8031Q29465808-2279A2E0-323C-4BD5-882F-443F8E97712AQ30418069-888F8073-628B-4DFE-8F07-3324AEF98D41Q30483143-7F4ACDB2-ADBA-4E66-995E-BA1D675BC606Q33267754-CD84E8BA-D976-44BD-BE17-B6477AC77B5AQ33374009-17390348-6413-4FC2-9553-51B4938F6DB0Q33553648-98C83B3F-7191-4B98-A876-4B26698AF59AQ33579851-B461218A-03FE-4818-8A21-6F2E60AC2D74Q33863096-B5B94373-75D0-467B-AE92-D3F1C72F8C23Q33899320-3754A3DB-D5FD-4862-A248-70895C4F6005
P2860
Hepatitis C virus entry: potential receptors and their biological functions.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hepatitis C virus entry: potential receptors and their biological functions.
@ast
Hepatitis C virus entry: potential receptors and their biological functions.
@en
type
label
Hepatitis C virus entry: potential receptors and their biological functions.
@ast
Hepatitis C virus entry: potential receptors and their biological functions.
@en
prefLabel
Hepatitis C virus entry: potential receptors and their biological functions.
@ast
Hepatitis C virus entry: potential receptors and their biological functions.
@en
P356
P1476
Hepatitis C virus entry: potential receptors and their biological functions.
@en
P2093
Cécile Voisset
P304
P356
10.1099/VIR.0.81646-0
P407
P577
2006-05-01T00:00:00Z